News
INCOG BioPharma Services builds state-of-the-art facility with promise to deliver a better customer experience
INCOG BioPharma Services, an Indiana-based contract development and manufacturing organization (CDMO) specializing in sterile injectables and seeking to deliver better customer experiences in the CDMO market, is nearing completion on the construction of its manufacturing facility and global headquarters...
News
Ardena expands capacity to satisfy Novavax COVID vaccine demand
Ardena, a specialist pharmaceutical contract development and manufacturing organisation (CDMO), announced it will be expanding its capacity for purification and fractionation of GMP manufacturing at its site in Södertälje, Sweden. The expansion will satisfy long-term demand expected from Novavax...
News
AstraZeneca Sells Half-Million COVID-19 Antibody Doses To US
After topping off supplies to Pfizer and GlaxoSmithkline, of the COVID-19 vaccine, US has sought AstraZeneca’s help of its antibody combo. Notably, the government has already bought another 500,000 doses of antibody cocktail Evusheld plus cilgavimab. This is in...
News
In Fight Against COVID-19 Ensovibep Paves A Concrete Path
The phase 2 EMPATHY top-line data which is a DARP in therapeutic antiviral used in the COVID-19 treatment suggests that measurable and meaningful benefits were seen from Ensovibep over the placebo. The trial is being conducted by Novartis and...
News
More Than 50% of Europe To Be Under The Clutches of Omicron
According to the forecast shared by WHO top officials more than half of Europe will suffer from the highly contagious variant of COVID-19, Omicron in the next couple of months. As per one of the top line directors at...
News
2022 Innovations To Look Out For In The Pharmaceutical Arena
The year that has gone by has had a phenomenal impact on the way we perceive things around us. The pandemic, which is still evolving through its numerous variants, has taught us to think out of the box, and...
News
COVID-19 Vaccines May Need Updation For Omicron- WHO Body
The technical body of the World Health Organization has confirmed that the COVID-19 vaccines, which the world is using currently, may have to be reworked to ensure their effectiveness against not only Omicron but future variants as well that...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read